Skip to Navigation

Cellectis

Search this site:

RSS
Facebook
Twitter

Home
About us
Our Science
Activities
Investors
Media
- Press Releases
- Pictures Library
Presse
- Communiqués de presse
- Photothèque
Careers
Agenda
Events

English
Français

Home

News & Events

Subscribe

»
Compact TALEN™: the next generation of TAL effector...

21/05/2013

ShareThis
»
TAL-effector nuclease: Issuance by the USPTO of Two New...

16/05/2013

ShareThis
»
David Sourdive, Vice President of Corporate Development at...

02/05/2013

ShareThis
»
Cellectis: 2012 financial results Operating performance in...

29/04/2013

ShareThis
»
Cellectis bioresearch launches VizuCELL cell lines for...

17/04/2013

ShareThis
»
Launching of CanCELL™ cell lines, featuring knock-out of...

08/04/2013

ShareThis
»
Cellectis and Stemgent Partner to Provide Custom Genome-...

07/03/2013

ShareThis
»
Cellectis announces appointment of Pierre Schwich as Group...

25/02/2013

ShareThis
»
Cellectis: an innovative anti-cancer approach. The...

18/12/2012

ShareThis
»
2012 Nobel laureate in medicine Shinya Yamanaka reaffirms...

12/11/2012

ShareThis

Read All News »

Agenda

Subscribe

2013 first-half earnings

26 September 2013

Paris

> Link

ShareThis
Paris Midcap Event

02 October 2013 - 03 October 2013

Palais Brongniart, Paris

> Link

ShareThis

View more Events » Export

Glossary
Multimedia
Privacy Policy
Contact us

Home
About us
Our Science
Activities
Investors
Media
- Press Releases
- Pictures Library
Careers
Agenda
Events

Subsidiaries

Cellectis bioresearch
Cellectis therapeutics
Cellectis plant sciences
Cellectis stem cells

EURONEXT Paris (ALCLS) 26/05/2013

16:41:04

€ 5.65

X

Enter your email address:

Delivered by FeedBurner